Optimal healthcare decisions: Comparing medical treatments on a cost-effectiveness basis

This paper deals with medical treatments comparison from the cost-effectiveness viewpoint. A decision theory scheme is considered, where the decision space is the set of treatments involved, the space of states of nature consists of the respective net benefits of the treatments, and the utility function is one of two possible candidates. A first candidate is the one typically used in the literature on cost-effectiveness analysis, for which the utility of a decision is proportional to the net benefit gain, and a second one is of the type 0-1, which penalizes the wrong decisions with a fixed quantity. Their associated optimal decision rules, both frequentist and Bayesian, are analyzed and compared via frequentist evaluation of their performance, and the conclusion is that the latter beats the former in the sense of choosing the optimal treatment more often than any other, thus minimizing the proportion of wrong decisions. Illustrations with simulated and real data are provided.

[1]  Daniel F Heitjan,et al.  Bayesian estimation of cost-effectiveness: an importance-sampling approach. , 2004, Health economics.

[2]  Andrew H Briggs,et al.  Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[3]  John C. Hershey,et al.  Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[4]  M. Weinstein,et al.  Theoretical issues in cost-effectiveness analysis. , 1997, Journal of health economics.

[5]  Xavier Badia,et al.  Bayesian regression models for cost-effectiveness analysis , 2005, The European Journal of Health Economics.

[6]  Karl Claxton,et al.  Selecting treatments: a decision theoretic approach , 2000 .

[7]  D Y Lin,et al.  Incremental net benefit in randomized clinical trials , 2001, Statistics in medicine.

[8]  A A Stinnett,et al.  Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  S G Thompson,et al.  Parametric modelling of cost data in medical studies , 2004, Statistics in medicine.

[10]  Parag C. Pendharkar,et al.  The relationship between software development team size and software development cost , 2009, CACM.

[11]  A O'Hagan,et al.  Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies , 2002, Statistical methods in medical research.

[12]  W. J. Hall,et al.  Approximating Priors by Mixtures of Natural Conjugate Priors , 1983 .

[13]  Andrew Briggs,et al.  Statistical Analysis of Cost-Effectiveness Data , 2006 .

[14]  M J Al,et al.  A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. , 2000, Health economics.

[15]  David J. Vanness,et al.  Perspectives on Mean-based Evaluation of Health Care , 2006 .

[16]  Andrew R Willan,et al.  Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. , 2008, Health economics.

[17]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[18]  A O'Hagan,et al.  A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.

[19]  Zaid Chalabi,et al.  Uncertainty and value of information when allocating resources within and between healthcare programmes , 2008, Eur. J. Oper. Res..

[20]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[21]  Simon G Thompson,et al.  How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions? , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  A O'Hagan,et al.  Bayesian cost‐effectiveness analysis from clinical trial data , 2001, Statistics in medicine.

[23]  Jeffrey S Hoch,et al.  Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope , 2006, BMC Health Services Research.

[24]  Paul R. Harper,et al.  OR in Health , 2008, Eur. J. Oper. Res..

[25]  David J. Spiegelhalter,et al.  Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.